12 February 2018
NovaMedica, a Russian pharmaceutical company and the investment project of RUSNANO, has announced the collaboration in the area of knowledge and technology transfer between NovaMedica Innotech, an R&D center, and Evonik, a German company and a leader in the global market of excipients for pharmaceutical industry.
This partnership will result in the establishment of a training center for the transfer of competencies in the area of pharmaceutical technology, which will be created in NovaMedica Innotech in Russia.
The coaches of Evonik will provide to the specialists of NovaMedica R&D the knowledge and technology on the use of excipients for designing the innovative properties of drugs. For example, these methods and substances are required in order to ensure the prolonged action of medicinal product, delayed release of the active ingredient, or its targeted delivery to the desired part of gastrointestinal tract, as well as to manufacture the injectable dosage forms with prolonged action and implants, liposomal and injectable nanosomal forms, pharmacopoeial amino acids, ingredients for improving the efficacy of nutrient environments in biotech processes, etc. After the training, the specialists of NovaMedica will transfer the obtained knowledge to their colleagues in Russian pharmaceutical companies.
14 March 2024
26 February 2024
NovaMedica team wishes you a Merry Christmas and a Happy New Year!
26 December 2023
Russian drug for the treatment of viral hepatitis will be exempt from duty in Mongolia
24 April 2024
PM Mishustin: “We need to increase the production of vital and essential drugs in Russia”
24 April 2024
The Future of Pharmacy: How Advancements in Technology Are Transforming the Field
23 April 2024
Analysis Forecasts Up to 16.5% of Population Will Have Chronic Kidney Disease by 2032
23 April 2024